Since 2018, my copy has generated more than $18,000,000 in sales in niches from fitness to travel and from survival to health ...

On an adjusted basis, the U.S. drugmaker expects to earn between $22.50 and $24.00 per share in 2025. Analysts were expecting ...

Eli Lilly shares rose Thursday after the drugmaker's adjusted profit came in above estimates, offsetting weaker-than-expected revenue.

The direct-to-consumer pool and spa care services company posted a net loss for the three months ended Dec. 28 of $44.6 million, or 24 cents a share, compared with a loss of $39.6 million, or 21 cents ...

Eli Lilly & Co. said its Type-2 Diabetes drug Mounjaro and weight-loss/diabetes medicine Zepbound drove a 45% increase in fourth-quarter revenue to $13.53 billion.

For years, accounting has been seen as a back-office function focused on compliance, managing financial records and ensuring tax filings are accurate. However, in recent years, accounting has evolved ...

Peloton Interactive generated strong cash flows and exceeded revenue expectations, yet faced challenges with subscriber ...

Q4 2024 Management View CEO Andy Nemeth highlighted key achievements in 2024, including solidifying their position in the Powersports and aftermarket markets through the acquisitions of Sportech and ...